Geneesmiddelenbeleid

This procedure is a report on a general consultation regarding the Netherlands' national medicines policy. It focuses on how the government manages the availability, pricing, and distribution of pharmaceutical products to ensure public health and sustainable healthcare spending. This affects healthcare providers, pharmaceutical companies, and patients by potentially altering how medicines are procured and reimbursed within the Dutch healthcare system.